comparemela.com

Latest Breaking News On - Silverarc capital management - Page 4 : comparemela.com

StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)

StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Evogene Price Performance Shares of EVGN stock opened at $0.77 on Friday. The company has a market capitalization of $31.73 million, a PE ratio of -1.67 […]

Silverarc-capital-management
Evogene-company-profile
Exchange-commission
Nasdaq
Evogene-ltd
Human-health
Free-report
Get-free-report
Capital-management
Computational-predictive-biology
Evogene-daily

Soleno Therapeutics (NASDAQ:SLNO) Trading Up 3.1%

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 3.1% during trading on Wednesday . The company traded as high as $42.04 and last traded at $42.04. Approximately 65,481 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 360,998 shares. The stock had previously closed […]

Robertw-baird
Bhatnagar-anish
Piper-sandler
Maven-securities
Vivo-capital
Securities-exchange-commission
Nasdaq
York-mellon-corp
Vivo-opportunity-llc
Soleno-therapeutics-inc
Silverarc-capital-management
Soleno-therapeutics

Kodiak Sciences Inc. (NASDAQ:KOD) Receives Consensus Recommendation of "Reduce" from Analysts

Shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received a consensus recommendation of “Reduce” from the seven analysts that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the […]

Monaco
Silverarc-capital-management
Analyst-recommendations-for-kodiak-sciences
Nasdaq
News-ratings-for-kodiak-sciences-daily
Barclays-plc
Kodiak-sciences-inc
Barclays
Kodiak-sciences-stock-performance
Kodiak-sciences-company-profile
Kodiak-sciences

Scholar Rock's (SRRK) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $30.00 price target on the stock. Several other research analysts also recently commented on the company. Piper Sandler restated an overweight rating and set a $28.00 price […]

China
Piper-sandler
Raymond-james
Walleye-trading
China-universal-asset-management-co
Silverarc-capital-management
Scholar-rock-company-profile
Scholar-rock-holding-corporation
Scholar-rock
Free-report
Truist-financial
Rock-stock-down

Benchmark Reiterates "Buy" Rating for Clene (NASDAQ:CLNN)

Benchmark restated their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of Clene in a research note on Wednesday, […]

Nasdaq
Clene-inc
Clene-company-profile
Silverarc-capital-management
Free-report
Get-free-report
Capital-management
Multiple-sclerosis
Clene-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.